Provincial and territorial routine vaccination programs for healthy, previously immunized adults

Download in PDF format
(PDF format, 221 KB, 1 page)

Organization: Public Health Agency of Canada

Date updated: January 2024

Last updated: January 2024

This table summarizes the current routine (publicly-funded) vaccination schedule for healthy, previously immunized adults in all provinces and territories (P/T) across Canada. P/T programs for publicly-funded programs can change. Schedules for each P/T can be found on their website and individuals are encouraged to talk to their health care providers about recommended immunizations for them. This table does not include adults who were previously unimmunized, adults with underlying medical conditions (at-risk), travelers, health care workers, etc. Please refer to the NACI recommendations or specific P/T schedules for more details on these groups.

The Canadian Immunization Guide is an online resource for health care professionals and includes more information about vaccines, vaccine safety, and the nationally recommended immunization schedules. Additional information on vaccine safety, epidemiology, and guidance on immunization and vaccines is available on ca-ciconline.com.

Provincial & Territorial Vaccination Schedules for Healthy, Previously Immunized Adults
Abbreviation	Description	BC	AB	SK	MB^{Table footnote 6}	ON	QC	NB	NS	PE	NL	YT	NT	NU
Tdap^{Table footnote 1}	Tetanus, diphtheria (reduced toxoid), acellular pertussis (reduced toxoid) vaccine	With each pregnancy	Every 10 years and each pregnancy	One booster dose per adult lifetime and each pregnancy	One booster dose per adult lifetime and each pregnancy	One booster dose per adult lifetime and each pregnancy	With each pregnancy	One booster dose per adult lifetime and each pregnancy	One booster dose per adult lifetime and each pregnancy	Every 10 years and each pregnancy	Every 10 years and each pregnancy	One booster dose per adult lifetime and each pregnancy	Every 10 years and each pregnancy	One booster dose per adult lifetime and each pregnancy
Td	Tetanus and diphtheria (reduced toxoid) vaccine	Every 10 years	N/A	Every 10 years	Every 10 years	Every 10 years	One dose at 50 years of age	Every 10 years	Every 10 years	N/A	N/A	Every 10 years	N/A	Every 10 years
Inf	Influenza vaccine	Annually for all adults	Annually for all adults	Annually for all adults	Annually for all adults	Annually for all adults	Annually for adults aged 75+years^{Table footnote 2}	Annually for all adults	Annually for all adults	Annually for all adults	Annually for all adults	Annually for all adults	Annually for all adults	Annually for all adults
Pneu-P-23	Pneumococcal polysaccharide (23-valent) vaccine	65+ years One dose	65+ years One dose	65+ years One dose	65+ years One dose	65+ years One dose	65+ years One dose	65+ years One dose	65+ years One dose	65+ years One dose	65+ years One dose	65+ years and all residents of extended or intermediate care facilities, and high-risk individuals One dose	65+ years One dose	50+ years One dose
Zos	Herpes Zoster (Shingles) vaccine	N/A	N/A	N/A	N/A	65 to 70 years Two doses	80+ years Two doses	N/A	N/A	60+ years Two doses	N/A	65 to 79 years Two doses	N/A	N/A
HPV	HPV vaccine	Less than 19 years and some adults less than 27 years^{Table footnote 5}	Less than 27 years^{Table footnote 4}	Females less than 27 years and males born after January 1, 2006^{Table footnote 10}	Healthy females born on or after January 1, 1997, and healthy males born on or after January 1, 2002^{Table footnote 7}, and some high-risk individuals^{Table footnote 8}	N/A	N/A	Less than 27 years	Some high-risk populations and a catch-up program^{Table footnote 9}	All adults^{Table footnote 3}	N/A	18 to 26 years and high-risk individuals up to 45 years	Up to 26 years of age	Less than 27 years^{Table footnote 4}
Footnote 1 NACI recommends that all adults should receive one dose of Tdap vaccine if they have not previously received pertussis-containing vaccines in adulthood and with every pregnancy Return to footnote 1 referrer Footnote 2 The influenza vaccine is no longer recommended for healthy adults aged 60 to 74 years. For the 2023-2024 season, even if the recommendations remain unchanged, the vaccine is offered free of charge for people aged 6 months and over. Return to footnote 2 referrer Footnote 3 The HPV vaccine is publicly funded for the adult program. The HPV vaccine is recommended for adults with the following risk factors: previous sexually transmitted infection, history of sexual abuse, early age of first sexual intercourse, number of lifetime sex partners, having unprotected sex with multiple partners (male and female) or with a partner who has multiple partners abnormal PAP test, immune suppression (and high risk practices), HIV infection, inconsistent condom use, men who have sex with men and all adults who self-identify as requiring HPV vaccine. Return to footnote 3 referrer Footnote 4 Anyone under the age of 27 is eligible to receive an HPV vaccine. Return to footnote 4 referrer Footnote 5 HIV+ individuals, cis-gender males who are MSM (or questioning), street involved, two-spirit, transgender or non-binary. Return to footnote 5 referrer Footnote 6 MB applies the following policy to any publicly-funded vaccines: "Once eligible always eligible", so individuals who do not receive a publicly-funded vaccine when it is first recommended are eligible to receive the vaccine anytime later (unless otherwise stated). Return to footnote 6 referrer Footnote 7 If they missed it as part of the school immunization program. Return to footnote 7 referrer Footnote 8 Individuals with at least one of the following high-risk criteria are eligible to receive up to 3 doses: Immunocompetent HIV-infected males 9-26 years of age and females 9-45 years of age. Males 9-26 years of age and females 9-45 years of age who have congenital immune deficiencies (B cell deficient, T cell mixed defects, phagocytic and neutrophil disorders, complement deficiency) or acquired immune deficiencies (pre-solid organ transplant or post-solid organ transplants, hematopoietic stem cell transplant recipients, as per CancerCare Manitoba Blood and Marrow Transplant (BMT) Immunization Schedule). Males ≤ 18 years of age who are, or who have ever been, incarcerated. Individuals who are currently, or who have previously been, diagnosed with recurrent respiratory papillomatosis. Males 9-26 years of age who identify as gay or bisexual Transgender males and transgender females 9-26 years of age. Females 9-45 years of age who have a newly diagnosed high-grade cervical histopathology result. Males 9-26 years of age and females 9-45 years of age who are victims of sexual assault. Patients currently under the care of a haematologist or oncologist from CancerCare Manitoba (CCMB) who have the following conditions and have been provided a CCMB directed Immunization Schedule: Malignant neoplasms (solid tissue and haematological) including leukemia and lymphoma, or clonal blood disorder, and who will receive or have completed immunosuppressive therapy including chemotherapy or radiation therapy, or Hypo- or asplenic (Sickle Cell Disease, etc.) Return to footnote 8 referrer Footnote 9 The HPV vaccine is offered to some high risk populations if they are less than 46 years of age and a catch-up program if an individual is less than 19 years of age. Return to footnote 9 referrer Footnote 10 Immunocompromised females and males less than 27 years are also eligible. Return to footnote 10 referrer N/A N/A - Vaccine is not publicly funded for adults in this province/territory

Page details

Date modified:: 2024-01-22

Language selection

Search

Provincial and territorial routine vaccination programs for healthy, previously immunized adults

Page details